Abstract
Maximal cardiac output is reduced in severe acute hypoxia but also in chronic hypoxia by mechanisms that remain poorly understood. In theory, the reduction of maximal cardiac output could result from: (1) a regulatory response from the central nervous system, (2) reduction of maximal pumping capacity of the heart due to insufficient coronary oxygen delivery prior to the achievement of the normoxic maximal cardiac output, or (3) reduced central command. In this review, we focus on the effects that acute and chronic hypoxia have on the pumping capacity of the heart, particularly on myocardial contractility and the molecular responses elicited by acute and chronic hypoxia in the cardiac myocytes. Special emphasis is put on the cardioprotective effects of chronic hypoxia. (Part of a multi-author review.)
Similar content being viewed by others
References
Calbet JA (2000) Oxygen tension and content in the regulation of limb blood flow. Acta Physiol Scand 168:465–472
Calbet JA, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140
Koskolou MD, Roach RC, Calbet JA, Radegran G, Saltin B (1997) Cardiovascular responses to dynamic exercise with acute anemia in humans. Am J Physiol 273:H1787–H1793
Ekblom B, Goldbarg AN, Gullbring B (1972) Response to exercise after blood loss and reinfusion. J Appl Physiol 33:175–180
Ekblom B, Huot R, Stein EM, Thorstensson AT (1975) Effect of changes in arterial oxygen content on circulation and physical performance. J Appl Physiol 39:71–75
Ekblom B, Huot R (1972) Response to submaximal and maximal exercise at different levels of carboxyhemoglobin. Acta Physiol Scand 86:474–482
Ekblom B, Wilson G, Astrand PO (1976) Central circulation during exercise after venesection and reinfusion of red blood cells. J Appl Physiol 40:379–383
Turner DL, Hoppeler H, Noti C, Gurtner HP, Gerber H, Schena F, Kayser B, Ferretti G (1993) Limitations to VO2max in humans after blood retransfusion. Respir Physiol 92:329–341
Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA (2008) Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport? J Appl Physiol 105:581–587
Neubauer B, Tetzlaff K, Staschen CM, Bettinghausen E (2001) Cardiac output changes during hyperbaric hyperoxia. Int Arch Occup Environ Health 74:119–122
Saltin B, Calbet JA (2006) Point: in health and in a normoxic environment, VO2max is limited primarily by cardiac output and locomotor muscle blood flow. J Appl Physiol 100:744–745
Calbet JA, Jensen-Urstad M, Van Hall G, Holmberg HC, Rosdahl H, Saltin B (2004) Maximal muscular vascular conductances during whole body upright exercise in humans. J Physiol 558:319–331
Calbet JA, Gonzalez-Alonso J, Helge JW, Sondergaard H, Munch-Andersen T, Boushel R, Saltin B (2007) Cardiac output and leg and arm blood flow during incremental exercise to exhaustion on the cycle ergometer. J Appl Physiol 103:969–978
Gonzalez-Alonso J, Calbet JA (2003) Reductions in systemic and skeletal muscle blood flow and oxygen delivery limit maximal aerobic capacity in humans. Circulation 107:824–830
Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, Saltin B (2003) Determinants of maximal oxygen uptake in severe acute hypoxia. Am J Physiol Regul Integr Comp Physiol 284:R291–R303
Calbet JA, Robach P, Lundby C, Boushel R (2008) Is pulmonary gas exchange during exercise in hypoxia impaired with the increase of cardiac output? Appl Physiol Nutr Metab 33:593–600
Lundby C, Calbet JA, van Hall G, Saltin B, Sander M (2004) Pulmonary gas exchange at maximal exercise in Danish lowlanders during eight weeks of acclimatization to 4,100 m and in high-altitude Aymara natives. Am J Physiol Regul Integr Comp Physiol 287:R1202–R1208
Wagner PD, Araoz M, Boushel R, Calbet JA, Jessen B, Radegran G, Spielvogel H, Sondegaard H, Wagner H, Saltin B (2002) Pulmonary gas exchange and acid–base state at 5,260 m in high-altitude Bolivians and acclimatized lowlanders. J Appl Physiol 92:1393–1400
Beall CM, Brittenham GM, Strohl KP, Blangero J, Williams-Blangero S, Goldstein MC, Decker MJ, Vargas E, Villena M, Soria R, Alarcon AM, Gonzales C (1998) Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 106:385–400
Calbet JA (2003) Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol 551:379–386
Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, Saltin B (2003) Why is VO2max after altitude acclimatization still reduced despite normalization of arterial O2 content? Am J Physiol Regul Integr Comp Physiol 284:R304–R316
Hansen J, Sander M (2003) Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol 546:921–929
Lundby C, Boushel R, Robach P, Moller K, Saltin B, Calbet JA (2008) During hypoxic exercise some vasoconstriction is needed to match O2 delivery with O2 demand at the microcirculatory level. J Physiol 586:123–130
Calbet JA, Radegran G, Boushel R, Sondergaard H, Saltin B, Wagner PD (2002) Effect of blood haemoglobin concentration on VO2max and cardiovascular function in lowlanders acclimatised to 5,260 m. J Physiol 545:715–728
Calbet JA, Radegran G, Boushel R, Saltin B (2009) On the mechanisms that limit oxygen uptake during exercise in acute and chronic hypoxia: role of muscle mass. J Physiol 587:477–490
Stenberg J, Ekblom B, Messin R (1966) Hemodynamic response to work at simulated altitude, 4,000 m. J Appl Physiol 21:1589–1594
Pugh LGCE (1964) Cardiac output in muscular exercise at 5,800 m (19,000 ft). J Appl Physiol 19:441–447
Sproule BJ, Mitchell JH, Miller WF (1960) Cardiopulmonary physiological responses to heavy exercise in patients with anemia. J Clin Invest 39:378–388
Reis DJ, Golanov EV, Ruggiero DA, Sun MK (1994) Sympatho-excitatory neurons of the rostral ventrolateral medulla are oxygen sensors and essential elements in the tonic and reflex control of the systemic and cerebral circulations. J Hypertens Suppl 12:S159–S180
Calbet JA, Lundby C (2009) Air to muscle O2 delivery during exercise at altitude. High Alt Med Biol 10:123–134
Piiper J, Scheid P (1981) Model for capillary-alveolar equilibration with special reference to O2 uptake in hypoxia. Respir Physiol 46:193–208
Dempsey JA, Wagner PD (1999) Exercise-induced arterial hypoxemia. J Appl Physiol 87:1997–2006
Johnson RLJ (1977) Oxygen transport. In: Willerson JT, Sanders CA (eds) Clinical cardiology. Grune & Stratton, New York, pp 74–84
Hopkins SR (2006) Exercise induced arterial hypoxemia: the role of ventilation-perfusion inequality and pulmonary diffusion limitation. Adv Exp Med Biol 588:17–30
Zanzinger J, Czachurski J, Seller H (1998) Nitric oxide in the ventrolateral medulla regulates sympathetic responses to systemic hypoxia in pigs. Am J Physiol 275:R33–R39
Sun MK, Reis DJ (1994) Central neural mechanisms mediating excitation of sympathetic neurons by hypoxia. Prog Neurobiol 44:197–219
Alexander JK, Hartley LH, Modelski M, Grover RF (1967) Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. J Appl Physiol 23:849–858
Janicki JS, Sheriff DD, Robotham JL, Wise RA (1996) Cardiac output during exercise: contributions of the cardiac, circulatory, and respiratory systems. In: Rowell LB, Shepherd JT (eds) Handbook of physiology. Exercise: regulation and integration of multiple systems. American Physiological Society, Bethesda, MD, pp 649–704
Barendsen GJ, van den Berg JW (1984) Venous capacity, venous refill time and the effectiveness of the calf muscle pump in normal subjects. Angiology 35:163–172
Disler DG, Cohen MS, Krebs DE, Roy SH, Rosenthal DI (1995) Dynamic evaluation of exercising leg muscle in healthy subjects with echo planar MR imaging: work rate and total work determine rate of T2 change. J Magn Reson Imaging 5:588–593
Sheriff DD, Van Bibber R (1998) Flow-generating capability of the isolated skeletal muscle pump. Am J Physiol 274:H1502–H1508
Sheriff D (2005) Point: the muscle pump raises muscle blood flow during locomotion. J Appl Physiol 99:371–372 (discussion 374–375)
Essop MF (2007) Cardiac metabolic adaptations in response to chronic hypoxia. J Physiol 584:715–726
Williams RS, Benjamin IJ (2000) Protective responses in the ischemic myocardium. J Clin Invest 106:813–818
McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX, Thompson CB, Hay N, Chandel NS (2002) Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 22:94–104
Jones DP (1986) Intracellular diffusion gradients of O2 and ATP. Am J Physiol 250:C663–C675
Wilson DF, Rumsey WL, Green TJ, Vanderkooi JM (1988) The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration. J Biol Chem 263:2712–2718
Schroedl C, McClintock DS, Budinger GR, Chandel NS (2002) Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283:L922–L931
Chandel NS, Vander Heiden MG, Thompson CB, Schumacker PT (2000) Redox regulation of p53 during hypoxia. Oncogene 19:3840–3848
Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88:5680–5684
Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757–23763
Semenza GL, Shimoda LA, Prabhakar NR (2006) Regulation of gene expression by HIF-1. Novartis Found Symp 272:2–8 (discussion 8–14, 33–36)
Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177–185
Semenza GL (2007) Regulation of tissue perfusion in mammals by hypoxia-inducible factor 1. Exp Physiol 92:988–991
Opie LH, Lopaschuk GD (2004) Fuels: aerobic and anaerobic metabolism. In: Weinberg RW, Bersin J, Aversa F (eds) Heart physiology. From cell to circulation. Lippincot Williams & Wilkins, Philadelphia, pp 306–354
Takaoka H, Takeuchi M, Odake M, Yokoyama M (1992) Assessment of myocardial oxygen consumption (VO2) and systolic pressure–volume area (PVA) in human hearts. Eur Heart J 13(Suppl E):85–90
Duncker DJ, Bache RJ (2008) Regulation of coronary blood flow during exercise. Physiol Rev 88:1009–1086
Messer JV, Wagman RJ, Levine HJ, Neill WA, Krasnow N, Gorlin R (1962) Patterns of human myocardial oxygen extraction during rest and exercise. J Clin Invest 41:725–742
Kitamura K, Jorgensen CR, Gobel FL, Taylor HL, Wang Y (1972) Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 32:516–522
Ross J Jr (1991) Myocardial perfusion–contraction matching. Implications for coronary heart disease and hibernation. Circulation 83:1076–1083
Braga VA, Zoccal DB, Soriano RN, Antunes VR, Paton JF, Machado BH, Nalivaiko E (2007) Activation of peripheral chemoreceptors causes positive inotropic effects in a working heart–brainstem preparation of the rat. Clin Exp Pharmacol Physiol 34:1156–1159
Braga VA, Soriano RN, Braccialli AL, de Paula PM, Bonagamba LG, Paton JF, Machado BH (2007) Involvement of l-glutamate and ATP in the neurotransmission of the sympathoexcitatory component of the chemoreflex in the commissural nucleus tractus solitarii of awake rats and in the working heart-brainstem preparation. J Physiol 581:1129–1145
Layland J, Grieve DJ, Cave AC, Sparks E, Solaro RJ, Shah AM (2004) Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. J Physiol 556:835–847
Hoh JF, Rossmanith GH, Kwan LJ, Hamilton AM (1988) Adrenaline increases the rate of cycling of crossbridges in rat cardiac muscle as measured by pseudo-random binary noise-modulated perturbation analysis. Circ Res 62:452–461
Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ (2001) Phosphorylation of troponin I by protein kinase a accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 88:1059–1065
Herron TJ, Korte FS, McDonald KS (2001) Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes. Circ Res 89:1184–1190
Kleinz MJ, Davenport AP (2004) Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 118:119–125
Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh T, Dargie H, Yakhini Z, Tsao PS, Quertermous T (2003) Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108:1432–1439
Kleinz MJ, Skepper JN, Davenport AP (2005) Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126:233–240
Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O’Dowd BF (2000) Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74:34–41
Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA, Yue P, Huynh DT, Connolly AJ, Pelletier MP, Tsao PS, Robbins RC, Quertermous T (2008) In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 294:H88–H98
Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O, Tavi P (2007) Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 21:1821–1830
Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M, Ruskoaho H (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91:434–440
Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, Marczin N, Szokodi I, Yacoub MH, Terracciano CM (2007) Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 357:889–895
Dai T, Ramirez-Correa G, Gao WD (2006) Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553:222–228
Cox CM, D’Agostino SL, Miller MK, Heimark RL, Krieg PA (2006) Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 296:177–189
Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F, Soubrier F (2008) Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 103:432–440
Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, Deng A, Eichhorn J, Mahajan R, Agrawal R, Greve J, Robbins R, Patterson AJ, Bernstein D, Quertermous T (2005) The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65:73–82
Cheng X, Cheng XS, Pang CC (2003) Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol 470:171–175
Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, Fujimiya M (2001) The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99:87–92
Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498–1505
Rassaf T, Flogel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J (2007) Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 100:1749–1754
Gladwin MT, Kim-Shapiro DB (2008) The functional nitrite reductase activity of the heme-globins. Blood 112:2636–2647
Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, Xu X, Murphy E, Darley-Usmar VM, Gladwin MT (2007) Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100:654–661
Brune B, Zhou J (2003) The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr Med Chem 10:845–855
Hagen T, Taylor CT, Lam F, Moncada S (2003) Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302:1975–1978
Brookes PS, Kraus DW, Shiva S, Doeller JE, Barone MC, Patel RP, Lancaster JR Jr, Darley-Usmar V (2003) Control of mitochondrial respiration by NO*, effects of low oxygen and respiratory state. J Biol Chem 278:31603–31609
Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A (1996) Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 328:85–92
Shiva S, Brookes PS, Patel RP, Anderson PG, Darley-Usmar VM (2001) Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc Natl Acad Sci USA 98:7212–7217
Thomas DD, Liu X, Kantrow SP, Lancaster JR Jr (2001) The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci USA 98:355–360
Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299:896–899
Kuwabara M, Kakinuma Y, Ando M, Katare RG, Yamasaki F, Doi Y, Sato T (2006) Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. J Physiol Sci 56:95–101
Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 102:13147–13152
Massion PB, Feron O, Dessy C, Balligand JL (2003) Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93:388–398
Seddon M, Shah AM, Casadei B (2007) Cardiomyocytes as effectors of nitric oxide signaling. Cardiovasc Res 75:315–326
Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810–22814
Xu KY, Kuppusamy SP, Wang JQ, Li H, Cui H, Dawson TM, Huang PL, Burnett AL, Kuppusamy P, Becker LC (2003) Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation. J Biol Chem 278:41798–41803
Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O’Hara DS, Kelly RA, Smith TW, Michel T (1995) Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270:14582–14586
Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96:657–662
Williams JC, Armesilla AL, Mohamed TM, Hagarty CL, McIntyre FH, Schomburg S, Zaki AO, Oceandy D, Cartwright EJ, Buch MH, Emerson M, Neyses L (2006) The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex. J Biol Chem 281:23341–23348
Gyurko R, Kuhlencordt P, Fishman MC, Huang PL (2000) Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278:H971–H981
Godecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J (2001) Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol 532:195–204
Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O’Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416:337–339
Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishman MC, Michel T, Kelly RA (1998) Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:6510–6515
Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R (1999) Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5:331–334
Martin SR, Emanuel K, Sears CE, Zhang YH, Casadei B (2006) Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 70:97–106
Sears CE, Ashley EA, Casadei B (2004) Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philos Trans R Soc Lond B Biol Sci 359:1021–1044
Ashley EA, Sears CE, Bryant SM, Watkins HC, Casadei B (2002) Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 105:3011–3016
Brunner F, Andrew P, Wolkart G, Zechner R, Mayer B (2001) Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104:3097–3102
Champion HC, Georgakopoulos D, Takimoto E, Isoda T, Wang Y, Kass DA (2004) Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ Res 94:657–663
Danson EJ, Zhang YH, Sears CE, Edwards AR, Casadei B, Paterson DJ (2005) Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression. Cardiovasc Res 67:613–623
Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL (2004) Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 110:2666–2672
Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, Rassaf T (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia–reperfusion injury. Proc Natl Acad Sci USA 105:10256–10261
Layland J, Li JM, Shah AM (2002) Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 540:457–467
Solaro RJ (2001) Modulation of cardiac myofilament activity by protein phosphorylation. In: Page E, Fozzard H, Solaro RJ (eds) Handbook of physiology, section 2: the cardiovascular system, vol 1: the heart. Oxford University Press, New York, pp 264–300
Bardenheuer H, Schrader J (1986) Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol 250:H173–H180
Schrader J, Baumann G, Gerlach E (1977) Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch 372:29–35
Sparks HV Jr, Bardenheuer H (1986) Regulation of adenosine formation by the heart. Circ Res 58:193–201
Berne RM (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204:317–322
Marshall JM (2007) The roles of adenosine and related substances in exercise hyperaemia. J Physiol 583:835–845
el-Ani D, Jacobson KA, Shainberg A (1994) Characterization of adenosine receptors in intact cultured heart cells. Biochem Pharmacol 48:727–735
Tikh EI, Fenton RA, Dobson JG Jr (2006) Contractile effects of adenosine A1 and A2A receptors in isolated murine hearts. Am J Physiol Heart Circ Physiol 290:H348–H356
Teng B, Ledent C, Mustafa SJ (2008) Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol 44:905–914
Fenton RA, Moore ED, Fay FS, Dobson JG Jr (1991) Adenosine reduces the Ca2+ transients of isoproterenol-stimulated rat ventricular myocytes. Am J Physiol 261:C1107–C1114
Monahan TS, Sawmiller DR, Fenton RA, Dobson JG Jr (2000) Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol 279:H1472–H1481
Woodiwiss AJ, Honeyman TW, Fenton RA, Dobson JG Jr (1999) Adenosine A2a-receptor activation enhances cardiomyocyte shortening via Ca2+-independent and -dependent mechanisms. Am J Physiol 276:H1434–H1441
Norton GR, Woodiwiss AJ, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JG Jr, Meyer TE (1999) Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart. Am J Physiol 276:H341–H349
LaMonica DA, Frohloff N, Dobson JG Jr (1985) Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol 248:H737–H744
Miyazaki K, Komatsu S, Ikebe M, Fenton RA, Dobson JG Jr (2004) Protein kinase cepsilon and the antiadrenergic action of adenosine in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 287:H1721–H1729
Kjaer M, Hanel B, Worm L, Perko G, Lewis SF, Sahlin K, Galbo H, Secher NH (1999) Cardiovascular and neuroendocrine responses to exercise in hypoxia during impaired neural feedback from muscle. Am J Physiol 277:R76–R85
Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Houston CS (1987) Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol 63:531–539
Kaijser L, Roach RC (1999) Myocardial blood flow and oxygen extraction in man after adaptation to high altitude. FASEB J 13:LB57
Roach RC, Koskolou MD, Calbet JA, Saltin B (1999) Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am J Physiol 276:H438–H445
Amann M, Calbet JA (2008) Convective oxygen transport and fatigue. J Appl Physiol 104:861–870
Hurtado A. (1960). Some clinical aspects of life at high altitudes Ann Intern Med 53
Mortimer E A Jr, Monson RR, MacMahon B (1977) Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 296:581–585
Poupa O, Krofta K, Prochazka J, Turek Z (1966) Acclimation to simulated high altitude and acute cardiac necrosis. Fed Proc 25:1243–1246
Meerson FZ, Gomzakov OA, Shimkovich MV (1973) Adaptation to high altitude hypoxia as a factor preventing development of myocardial ischemic necrosis. Am J Cardiol 31:30–34
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
Tissier R, Berdeaux A, Ghaleh B, Couvreur N, Krieg T, Cohen MV, Downey JM (2008) Making the heart resistant to infarction: how can we further decrease infarct size? Front Biosci 13:284–301
Das M, Das DK (2008) Molecular mechanism of preconditioning. IUBMB Life 60:199–203
Murphy E, Steenbergen C (2008) Mechanisms underlying acute protection from cardiac ischemia–reperfusion injury. Physiol Rev 88:581–609
Speechly-Dick ME, Mocanu MM, Yellon DM (1994) Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 75:586–590
Gopalakrishna R, Anderson WB (1989) Ca2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA 86:6758–6762
Seko Y, Tobe K, Takahashi N, Kaburagi Y, Kadowaki T, Yazaki Y (1996) Hypoxia and hypoxia/reoxygenation activate Src family tyrosine kinases and p21ras in cultured rat cardiac myocytes. Biochem Biophys Res Commun 226:530–535
Song C, Vondriska TM, Wang GW, Klein JB, Cao X, Zhang J, Kang YJ, D’Souza S, Ping P (2002) Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase. Am J Physiol Heart Circ Physiol 282:H1166–H1171
Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, Trush MA, Semenza GL (2008) Complete loss of ischemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1alpha. Cardiovasc Res 77:463–470
Dewald O, Sharma S, Adrogue J, Salazar R, Duerr GD, Crapo JD, Entman ML, Taegtmeyer H (2005) Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation 112:407–415
Neckar J, Szarszoi O, Herget J, Ostadal B, Kolar F (2003) Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia. Physiol Res 52:171–175
Rakusan K, Cicutti N, Kolar F (2001) Cardiac function, microvascular structure, and capillary hematocrit in hearts of polycythemic rats. Am J Physiol Heart Circ Physiol 281:H2425–H2431
Zungu M, Young ME, Stanley WC, Essop MF (2008) Expression of mitochondrial regulatory genes parallels respiratory capacity and contractile function in a rat model of hypoxia-induced right ventricular hypertrophy. Mol Cell Biochem 318:175–181
Opie LH (1969) Metabolism of the heart in health and disease. II. Am Heart J 77:100–122
Manchester J, Kong X, Nerbonne J, Lowry OH, Lawrence J C Jr (1994) Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism. Am J Physiol 266:E326–E333
Feldhaus LM, Liedtke AJ (1998) mRNA expression of glycolytic enzymes and glucose transporter proteins in ischemic myocardium with and without reperfusion. J Mol Cell Cardiol 30:2475–2485
Ye G, Donthi RV, Metreveli NS, Epstein PN (2005) Overexpression of hexokinase protects hypoxic and diabetic cardiomyocytes by increasing ATP generation. Cardiovasc Toxicol 5:293–300
Holden JE, Stone CK, Clark CM, Brown WD, Nickles RJ, Stanley C, Hochachka PW (1995) Enhanced cardiac metabolism of plasma glucose in high-altitude natives: adaptation against chronic hypoxia. J Appl Physiol 79:222–228
Ullah MS, Davies AJ, Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 281:9030–9037
McClelland GB, Brooks GA (2002) Changes in MCT 1, MCT 4, and LDH expression are tissue specific in rats after long-term hypobaric hypoxia. J Appl Physiol 92:1573–1584
van Hall G, Calbet JA, Sondergaard H, Saltin B (2001) The re-establishment of the normal blood lactate response to exercise in humans after prolonged acclimatization to altitude. J Physiol 536:963–975
Issekutz B Jr, Shaw WA, Issekutz TB (1975) Effect of lactate on FFA and glycerol turnover in resting and exercising dogs. J Appl Physiol 39:349–353
Boehm EA, Jones BE, Radda GK, Veech RL, Clarke K (2001) Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart Circ Physiol 280:H977–H983
Daneshrad Z, Garcia-Riera MP, Verdys M, Rossi A (2000) Differential responses to chronic hypoxia and dietary restriction of aerobic capacity and enzyme levels in the rat myocardium. Mol Cell Biochem 210:159–166
Kennedy SL, Stanley WC, Panchal AR, Mazzeo RS (2001) Alterations in enzymes involved in fat metabolism after acute and chronic altitude exposure. J Appl Physiol 90:17–22
Ngumbela KC, Sack MN, Essop MF (2003) Counter-regulatory effects of incremental hypoxia on the transcription of a cardiac fatty acid oxidation enzyme-encoding gene. Mol Cell Biochem 250:151–158
Huss JM, Levy FH, Kelly DP (2001) Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 276:27605–27612
Razeghi P, Young ME, Abbasi S, Taegtmeyer H (2001) Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart. Biochem Biophys Res Commun 287:5–10
Semenza GL (2007) Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405:1–9
Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129:111–122
Cervos Navarro J, Kunas RC, Sampaolo S, Mansmann U (1999) Heart mitochondria in rats submitted to chronic hypoxia. Histol Histopathol 14:1045–1052
Ostadal B, Kolar F (2007) Cardiac adaptation to chronic high-altitude hypoxia: beneficial and adverse effects. Respir Physiol Neurobiol 158:224–236
Kolar F, Neckar J, Ostadal B (2005) MCC-134, a blocker of mitochondrial and opener of sarcolemmal ATP-sensitive K+ channels, abrogates cardioprotective effects of chronic hypoxia. Physiol Res 54:467–471
Hrbasova M, Novotny J, Hejnova L, Kolar F, Neckar J, Svoboda P (2003) Altered myocardial Gs protein and adenylyl cyclase signaling in rats exposed to chronic hypoxia and normoxic recovery. J Appl Physiol 94:2423–2432
Asemu G, Papousek F, Ostadal B, Kolar F (1999) Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial K(ATP) channel. J Mol Cell Cardiol 31:1821–1831
Meerson FZ, Ustinova EE, Orlova EH (1987) Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol 10:783–789
Neckar J, Ostadal B, Kolar F (2004) Myocardial infarct size-limiting effect of chronic hypoxia persists for five weeks of normoxic recovery. Physiol Res 53:621–628
Tajima M, Katayose D, Bessho M, Isoyama S (1994) Acute ischemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. Cardiovasc Res 28:312–319
Neckar J, Papousek F, Novakova O, Ost’adal B, Kolar F (2002) Cardioprotective effects of chronic hypoxia and ischemic preconditioning are not additive. Basic Res Cardiol 97:161–167
Asemu G, Neckar J, Szarszoi O, Papousek F, Ostadal B, Kolar F (2000) Effects of adaptation to intermittent high altitude hypoxia on ischemic ventricular arrhythmias in rats. Physiol Res 49:597–606
Haddad F, Hunt SA, Rosenthal DN, Murphy DJ (2008) Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 117:1436–1448
Pei JM, Yu XC, Fung ML, Zhou JJ, Cheung CS, Wong NS, Leung MP, Wong TM (2000) Impaired 8G(s)alpha and adenylyl cyclase cause beta-adrenoceptor desensitization in chronically hypoxic rat hearts. Am J Physiol Cell Physiol 279:C1455–C1463
Pei JM, Zhou JJ, Bian JS, Yu XC, Fung ML, Wong TM (2000) Impaired [Ca(2 +)](i) and pH(i) responses to kappa-opioid receptor stimulation in the heart of chronically hypoxic rats. Am J Physiol Cell Physiol 279:C1483–C1494
Shan J, Yu XC, Fung ML, Wong TM (2002) Attenuated “cross talk” between kappa-opioid receptors and beta-adrenoceptors in the heart of chronically hypoxic rats. Pflugers Arch 444:126–132
Pei JM, Kravtsov GM, Wu S, Das R, Fung ML, Wong TM (2003) Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study. Am J Physiol Cell Physiol 285:C1420–C1428
Gregg DE, Khouri EM, Donald DE, Lowensohn HS, Pasyk S (1972) Coronary circulation in the conscious dog with cardiac neural ablation. Circ Res 31:129–144
DiCarlo SE, Blair RW, Bishop VS, Stone HL (1988) Role of beta 2-adrenergic receptors on coronary resistance during exercise. J Appl Physiol 64:2287–2293
Gwirtz PA, Mass HJ, Strader JR, Jones CE (1988) Coronary and cardiac responses to exercise after chronic ventricular sympathectomy. Med Sci Sports Exerc 20:126–135
Chilian WM, Harrison DG, Haws CW, Snyder WD, Marcus ML (1986) Adrenergic coronary tone during submaximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels. Circ Res 58:68–82
Semenza GL, Prabhakar NR (2007) HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 9:1391–1396
Calbet JA, Radegran G, Boushel R, Sondergaard H, Saltin B, Wagner PD (2004) Plasma volume expansion does not increase maximal cardiac output or VO2max in lowlanders acclimatized to altitude. Am J Physiol Heart Circ Physiol 287:H1214–H1224
Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, Saltin B (2001) Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation 104:1785–1791
Suarez J, Alexander JK, Houston CS (1987) Enhanced left ventricular systolic performance at high altitude during Operation Everest II. Am J Cardiol 60:137–142
Robach P, Calbet JA, Thomsen JJ, Boushel R, Mollard P, Rasmussen P, Lundby C (2008) The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia. PLoS ONE 3:e2996
Acknowledgment
The authors express their gratitude to James P. Fisher for his careful revision of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calbet, J.A.L., Robach, P. & Lundby, C. The exercising heart at altitude. Cell. Mol. Life Sci. 66, 3601–3613 (2009). https://doi.org/10.1007/s00018-009-0148-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-009-0148-6